Publications by authors named "Angeline Ginzac"

Claim this Profile
M
Melatonin supplementation for quality of life in older patients with advanced cancer: a randomized controlled trial.
Angeline Ginzac, Emmanuelle Bourbouloux, Romain Rivoirard, Christelle Jouannaud, Marie-Odile Hager

BMC Geriatr· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Exploring screening practices for sexual disorders in breast cancer patients].
Caroline Jacquet, Catherine Abrial, Céleste Pinard, Xavier Durando, Angeline Ginzac

Soins· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Exploring the concept of Total Pain in contemporary oncology palliative care: a qualitative study on patients' resources.
Maya Corman, Michaël Dambrun, Angeline Ginzac, Katell Ménard

BMC Palliat Care· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patient satisfaction with radio-frequency identification (RFID) tag localization compared with wire localization for nonpalpable breast lesions: the RFID trial.
Raphaël Pete, Céleste Pinard, Fanny Sirodot, Ioana Molnar, Margot Dressaire, Angeline Ginzac

BMC Cancer· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of new candidate genes for the hereditary predisposition to uveal melanoma: IGCMU trial.
Mélanie Godiveau, Angeline Ginzac, Yannick Bidet, Flora Ponelle-Chachuat, Maud Privat

Front Oncol· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preoperative stereotactic radiotherapy for the management of brain metastases.
Julian Biau, Florent Guillemin, Angeline Ginzac, Julie Villa, Gilles Truc

Cancer Radiother· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neoadjuvant anthracycline-based (5-FEC) or anthracycline-free (docetaxel/carboplatin) chemotherapy plus trastuzumab and pertuzmab in HER2 + BC patients according to their TOP2A: a multicentre, open-label, non-randomized phase II trial.
Angeline Ginzac, Ioana Molnar, Xavier Durando, Thibault De La Motte Rouge, Thierry Petit

Breast Cancer Res Treat· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Non-invasive intracranial pressure monitoring for high-grade gliomas patients treated with radiotherapy: results of the GMaPIC trial.
Mélanie Casile, Emilie Thivat, Fabrice Giraudet, Angeline Ginzac, Ioana Molnar

Front Oncol· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase-II study based on dose adjustment according to UGT1A1 polymorphism: is irinotecan underdosed in first-line FOLFIRI regimen for mCRC?
Angeline Ginzac, Emilie Thivat, Caroline Petorin, Damien Richard, Pauline Herviou

Cancer Chemother Pharmacol· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prediction of residual disease using circulating DNA detection after potentiated radiotherapy for locally advanced head and neck cancer (NeckTAR): a study protocol for a prospective, multicentre trial.
Angeline Ginzac, Marie-Céleste Ferreira, Anne Cayre, Clément Bouvet, Julian Biau

BMC Cancer· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
RFID trial: localization of non-palpable breast lesions using radiofrequency identification tags or wire.
Hugo Veyssiere, Margot Dressaire, Raphaël Pete, Céleste Pinard, Ioana Molnar, Angeline Ginzac

BMC Cancer· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Body Mass Index, Sarcopenia, and Their Variations in Predicting Outcomes for Patients Treated with Nivolumab for Metastatic Renal Cell Carcinoma.
Tressie Herrmann, Cécile Mione, Pierre-François Montoriol, Ioana Molnar, Angeline Ginzac

Oncology· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adapted Physical Activity for Breast Cancer Patients Treated with Neoadjuvant Chemotherapy and Trastuzumab Against HER2 (APACAN2): A Protocol for a Feasibility Study.
Angeline Ginzac, Maureen Bernadach, Ioana Molnar, Martine Duclos, Emilie Thivat

Front Oncol· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Eosinophil counts as a relevant prognostic marker for response to nivolumab in the management of renal cell carcinoma: a retrospective study.
Tressie Herrmann, Angeline Ginzac, Ioana Molnar, Sébastien Bailly, Xavier Durando

Cancer Med· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
X
XENOBREAST Trial: A prospective study of xenografts establishment from surgical specimens of patients with triple negative or luminal b breast cancer.
Hugo Veyssière, Judith Passildas, Angeline Ginzac, Sejdi Lusho, Yannick Bidet

F1000Res· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preoperative stereotactic radiosurgery for brain metastases: the STEP study protocol for a multicentre, prospective, phase-II trial.
Angeline Ginzac, Guillaume Dupic, Lucie Brun, Ioana Molnar, Mélanie Casile

BMC Cancer· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predictive factors of toxicity of TPF induction chemotherapy for locally advanced head and neck cancers.
Maureen Bernadach, Michel Lapeyre, Anne-Françoise Dillies, Jessica Miroir, Melanie Casile, Angeline Ginzac

BMC Cancer· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sister Mary Joseph Nodules: A Case Report about a Rare Location of Skin Metastasis.
Brice Leyrat, Maureen Bernadach, Angeline Ginzac, Sejdi Lusho, Xavier Durando

Case Rep Oncol· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pembrolizumab as a novel therapeutic option for patients with refractory thymic epithelial tumor: A case report.
Jonathan Wong-Chong, Maureen Bernadach, Angeline Ginzac, Hugo Veyssière, Xavier Durando

World J Clin Cases· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quality of life for older patients with cancer: a review of the evidence supporting melatonin use.
Angeline Ginzac, Sophie Dubois, Marie-Odile Hager, Fabrice Kwiatkowski, Judith Passildas

Aging Clin Exp Res· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Continuous Wound Infiltration With Ropivacaine After Mastectomy: A Randomized Controlled Trial.
Marie Beguinot, Emilie Monrigal, Fabrice Kwiatkowski, Angeline Ginzac, Dominique Joly

J Surg Res· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A decrease in brown adipose tissue activity is associated with weight gain during chemotherapy in early breast cancer patients.
Angeline Ginzac, Bertrand Barres, Marion Chanchou, Emilie Gadéa, Ioana Molnar

BMC Cancer· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment-Induced Cardiotoxicity in Breast Cancer: A Review of the Interest of Practicing a Physical Activity.
Angeline Ginzac, Judith Passildas, Emilie Gadéa, Catherine Abrial, Ioana Molnar

Oncology· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of Chemotherapy-induced Menopause in Women of Childbearing Age With Non-metastatic Breast Cancer - Preliminary Results From the MENOCOR Study.
Judith Passildas, Olivier Collard, Aude-Marie Savoye, Joyce Dohou, Angeline Ginzac

Clin Breast Cancer· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
Weight Evolution During Endocrine Therapy for Breast Cancer in Postmenopausal Patients: Effect of Initial Fat Mass Percentage and Previous Adjuvant Treatments.
Angeline Ginzac, Émilie Thivat, Marie-Ange Mouret-Reynier, Pascale Dubray-Longeras, Isabelle Van Praagh

Clin Breast Cancer· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis